Dirk Vlasselaers

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*

Miet Schetz, G. Van den Berghe, P. Ferdinande, 2003, Critical care medicine.

Intensive Insulin Therapy in Critically Ill Patients: NICE-SUGAR or Leuven Blood Glucose Target?

Miet Schetz, Dieter Mesotten, G. Van den Berghe, 2009 .

Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study

Greet Van den Berghe, Ilse Vanhorebeek, Geert Meyfroidt, 2009, The Lancet.

Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery.

Bart Meyns, Ilse Vanhorebeek, Patrick Wouters, 2010, The Annals of thoracic surgery.

Influence of inflow cannula length in axial-flow pumps on neurologic adverse event rate: results from a multi-center analysis.

Gino Gerosa, Bart Meyns, Volkmar Falk, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Intensive insulin therapy: enhanced Model Predictive Control algorithm versus standard care

Malgorzata E. Wilinska, Roman Hovorka, Ludovic J. Chassin, 2008, Intensive Care Medicine.

Intensive insulin therapy: enhanced Model Predictive Control algorithm versus standard care

Malgorzata E. Wilinska, Roman Hovorka, Greet Van den Berghe, 2008, Intensive Care Medicine.

Intensive insulin therapy protects the endothelium of critically ill patients.

Ilse Vanhorebeek, Kristin Skogstrand, G. Van den Berghe, 2005, The Journal of clinical investigation.